Antigen-presenting cell vaccine

An antigen-presenting cell vaccine, or an APC vaccine, is a vaccine made of antigens and antigen-presenting cells (APCs).

As of March 2019[update], the only APC vaccine approved by the American Food and Drug Administration is for prostatic acid phosphatase, a commonly over-expressed prostate cancer antigen.[1][2]

## References

[edit]

1. ^ O'Neill, David W. (November 2010). "Dendritic cells and T cells in immunotherapy". Journal of Drugs in Dermatology: JDD. 9 (11): 1383–1392. ISSN 1545-9616. PMID 21061761.
2. ^ Marc S. Ernstoff; Igor Puzanov; Caroline Robert; Adi M. Diab; Peter M. Hersey (2019-03-15). SITC's Guide to Managing Immunotherapy Toxicity. Springer Publishing Company. pp. xviii. ISBN 978-0-8261-7215-0.

## External links

[edit]

* Antigen-presenting cell vaccine entry in the public domain NCI Dictionary of Cancer Terms

This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.

This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it.

|

* v
* t
* e

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template